408 related articles for article (PubMed ID: 20217173)
1. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA.
Shidara K; Hoshi D; Inoue E; Yamada T; Nakajima A; Taniguchi A; Hara M; Momohara S; Kamatani N; Yamanaka H
Mod Rheumatol; 2010 Jun; 20(3):280-6. PubMed ID: 20217173
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for total knee arthroplasty in rheumatoid arthritis.
Momohara S; Inoue E; Ikari K; Kawamura K; Tsukahara S; Mochizuki T; Toki H; Miyawaki M; Saito S; Hara M; Kamatani N; Yamanaka H; Tomatsu T
Mod Rheumatol; 2007; 17(6):476-80. PubMed ID: 18084699
[TBL] [Abstract][Full Text] [Related]
3. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
[TBL] [Abstract][Full Text] [Related]
4. Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA.
Nakajima A; Inoue E; Tanaka E; Singh G; Sato E; Hoshi D; Shidara K; Hara M; Momohara S; Taniguchi A; Kamatani N; Yamanaka H
Scand J Rheumatol; 2010; 39(5):360-7. PubMed ID: 20476859
[TBL] [Abstract][Full Text] [Related]
5. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Sawada T; Inokuma S; Sato T; Otsuka T; Saeki Y; Takeuchi T; Matsuda T; Takemura T; Sagawa A;
Rheumatology (Oxford); 2009 Sep; 48(9):1069-72. PubMed ID: 19321513
[TBL] [Abstract][Full Text] [Related]
6. Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
Atzeni F; Boiardi L; Sallì S; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2013 Jul; 9(7):649-57. PubMed ID: 23899235
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
[TBL] [Abstract][Full Text] [Related]
8. Interstitial pneumonitis associated with infliximab therapy.
Villeneuve E; St-Pierre A; Haraoui B
J Rheumatol; 2006 Jun; 33(6):1189-93. PubMed ID: 16622902
[TBL] [Abstract][Full Text] [Related]
9. Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody.
Mori S; Imamura F; Kiyofuji C; Sugimoto M
Mod Rheumatol; 2006; 16(4):251-5. PubMed ID: 16906378
[TBL] [Abstract][Full Text] [Related]
10. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
[TBL] [Abstract][Full Text] [Related]
11. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
[TBL] [Abstract][Full Text] [Related]
12. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
Hyldgaard C; Hilberg O; Pedersen AB; Ulrichsen SP; Løkke A; Bendstrup E; Ellingsen T
Ann Rheum Dis; 2017 Oct; 76(10):1700-1706. PubMed ID: 28611082
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
Shimizu Y; Nakajima A; Inoue E; Shidara K; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H
Clin Rheumatol; 2017 Jun; 36(6):1237-1245. PubMed ID: 28455827
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
[TBL] [Abstract][Full Text] [Related]
16. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
[TBL] [Abstract][Full Text] [Related]
17. Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database.
Seto Y; Tanaka E; Inoue E; Nakajima A; Taniguchi A; Momohara S; Yamanaka H
Mod Rheumatol; 2011 Dec; 21(6):579-93. PubMed ID: 21424533
[TBL] [Abstract][Full Text] [Related]
18. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
19. Assessment of statin-induced interstitial pneumonia in patients treated for hyperlipidemia using a health insurance claims database in Japan.
Momo K; Takagi A; Miyaji A; Koinuma M
Pulm Pharmacol Ther; 2018 Jun; 50():88-92. PubMed ID: 29627482
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study.
Furuya T; Oh K; Ikari K; Inoue E; Tanaka E; Yamanaka H; Harigai M
Clin Rheumatol; 2022 Feb; 41(2):405-410. PubMed ID: 34586516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
